Related Experiment Videos

[Silent myocardial ischemia in outpatients being treated for hyperlipoproteinemia]

M Tomecková1, V Danzig, J Bultas

  • 1II. interní klinika 1. LF UK a VFN, Praha.

Casopis Lekaru Ceskych
|August 23, 1995
PubMed

Insights

Hyperlipoproteinaemia, a condition linked to high cholesterol, significantly increases the risk of silent myocardial ischaemia. Load testing and ECG monitoring are effective screening methods for this asymptomatic heart condition.

Area of Science:

  • Cardiology
  • Metabolic Disorders
  • Preventive Medicine

Context:

  • Hyperlipoproteinaemias, particularly hypercholesterolaemia, are established risk factors for atherogenesis.
  • Silent myocardial ischaemia, an asymptomatic form of coronary heart disease, poses a significant health concern.

Purpose:

  • To determine the prevalence of silent myocardial ischaemia in individuals with hyperlipoproteinaemia.
  • To evaluate the optimal diagnostic procedures for detecting silent myocardial ischaemia in this high-risk group.

Summary:

  • A study of 57 patients with hyperlipoproteinaemia revealed a prevalence of 13% in men and 11.8% in women for silent myocardial ischaemia.
  • Diagnostic procedures included ergometric loading tests, 24-hour ambulatory ECG monitoring, and load scintigraphy.

Impact:

  • Silent myocardial ischaemia is significantly more prevalent in individuals with hyperlipoproteinaemia compared to the general population.
  • Ergometric testing and ambulatory ECG monitoring, supported by scintigraphy, are recommended as effective screening tools.
Abstract

Related Concept Videos